Home
Clinical Trials
Partnerships
Contact Us
News & Resources
Careers
About Us
Management Team
Board of Directors
Scientific and Clinical Advisory Boards
Commercial Advisory Board
Our Focus
Infectious Disease
Oncology
Our Pipeline
Prophylactic
Therapeutic
Clinical Trials
Publications
Early/Expanded Access Policy
Our Science and Technology
Investors
Press Releases
Events and Presentations
Company Information
Stock Information
SEC Filings
Corporate Governance
About Us
Management Team
Board of Directors
Scientific and Clinical Advisory Boards
Commercial Advisory Board
Our Focus
Infectious Diseases
Oncology
Our Pipeline
Prophylactic
Therapeutic
Clinical Trials
Publications
Early/Expanded Access Policy
Our Science and Technology
News and Resources
News
Posters
Publications
Videos
Investors
Press Releases
Company Information
Corporate Governance
Events and Presentations
SEC Filings
Stock Information
Careers
Partnerships
Contact Us
Search our website
Video
VBI-1901: Phase 2a Data & Clinical Update in Recurrent GBM
November 19th, 2020
VBI-1901: AACR Data and Clinical Update in Recurrent GBM
June 22nd, 2020
Overview of First- and Second-Generation Hepatitis B Vaccines
October 27th, 2016
Overview of the Design of VBI-1901, VBI’s Therapeutic Cancer Vaccine Candidate
October 26th, 2016
Preclinical Data from VBI-1901, VBI’s Therapeutic Cancer Vaccine Candidate
October 25th, 2016
About Medulloblastoma
October 25th, 2016
About Glioblastoma (GBM)
October 25th, 2016
About Hepatitis B (HBV)
October 15th, 2016
Overview of VBI-1501, VBI’s Cytomegalovirus (CMV) Vaccine Candidate
August 15th, 2014
Overview of VBI’s Enveloped Virus-Like Particle (eVLP) Platform Technology
August 5th, 2014
Sign-up for Our Distribution List to Receive the Latest News and Updates from VBI
Sign Up Now
